Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR
This triple-combination antidiabetic medication, containing glimepiride, metformin hydrochloride, and voglibose (1mg/500mg/0.2mg SR), manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and have readily available glucose (e.g., sugary foods, fruit juice). Alcohol consumption increases this risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function.
Primary Ingredients of Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg SR Tablet on an empty stomach.
Common Side effects of Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablets whole; do not break, crush, or chew them. Consume Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg SR tablets on an empty stomach.
How Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR works:
A single tablet, Genericart, combines glimepiride (1mg), metformin hydrochloride (500mg), and voglibose (0.2mg) in a sustained-release formulation to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The combination medication Glimepiride/Metformin Hydrochloride/Voglibose (1mg/500mg/0.2mg SR) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The combination medication Glimepiride+Metformin Hydrochloride+Voglibose (Genericart, 1mg/500mg/0.2mg SR tablet) is likely not safe for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The combined medication Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR poses a potential risk for individuals with kidney impairment and its use should be avoided. Medical advice is essential. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimepiride/Metformin Hydrochloride/Voglibose 1mg/500mg/0.2mg SR tablets cautiously. Dosage modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; this medication is unsuitable for patients with severe hepatic dysfunction.
What if you forget to take Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR :
Should you forget to take your Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR, ingest it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Genericart Glimepiride+Metformin Hydrochloride+Voglibose 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently